Transgene SA (EPA:TNG)
France flag France · Delayed Price · Currency is EUR
0.6180
-0.0060 (-0.97%)
Apr 28, 2025, 11:07 AM CET

Transgene Company Description

Transgene SA, a biotechnology company, designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer in France.

It involved in developing TG4050, a therapeutic vaccine that is in Phase II clinical trial for the treatment of ovarian cancer, and head and neck cancers; TG4001, a therapeutic vaccine, which is in Phase II clinical trial for the treatment of human papillomavirus (HPV 16) positive cancers; TG6002, an oncolytic virus that is in Phase I/IIa clinical trial for the treatment of solid tumors, including gastrointestinal adenocarcinoma; and BT-001, an oncolytic virus, which is in Phase I/II clinical trial for the treatment of solid tumors.

The company also develops TG6050 for the treatment of non-small cell lung cancer that is in Phase 1 clinical trial; and Pexa-Vec, an oncolytic virus for the treatment of solid tumors.

It has strategic collaboration agreements with AstraZeneca, Merck KGaA, Pfizer, and NEC Corporation; licensing agreements with SillaJen, Ascend BioPharmaceutical, and Valneva; and agreements with Merck & Co, Sanofi, and BioInvent.

The company was incorporated in 1979 and is headquartered in Illkirch-Graffenstaden, France. Transgene SA is a subsidiary of TSGH SAS.

Transgene SA
Transgene logo
Country France
Founded 1979
Industry Biotechnology
Sector Healthcare
Employees 144
CEO Alessandro Riva

Contact Details

Address:
400, boulevard Gonthier d’Andernach
Illkirch-Graffenstaden, 67405
France
Phone 33 3 88 27 91 00
Website transgene.fr

Stock Details

Ticker Symbol TNG
Exchange Euronext Paris
Fiscal Year January - December
Reporting Currency EUR
ISIN Number FR0005175080
SIC Code 2836

Key Executives

Name Position
Dr. Alessandro Riva M.D. Chief Executive Officer and Chairman of the Board
Lucie Larguier Chief Financial Officer
Dr. Simone Silva Steiner Ph.D. Chief Technical Officer
Dr. Maurizio Ceppi Vice President and Chief Scientific Officer
John Felitti J.D., LLM Vice President, General Counsel and Corporate Secretary
Christelle Schwoerer Chief Human Resources Officer
James Wentworth M.B.A., Ph.D. Vice President and Chief Business Officer
Emmanuelle Dochy M.D. Vice President of Medical Affairs and Chief Medical Officer
Gaelle Stadtler Vice President and Director of Human Resources